Industry reports
Editor highlights

Pathology Industry in the United Kingdom: Market Research Reports, Statistics and Analysis

You might be interested in: cancer, mental health, cardiovascular disease, more »

» View Public Reports

About 500 reports

Pharmaceutical Market in The United Kingdom

  • Industry report
  • December 2013
  • 22 pages

... In england at record levels, rising by 20% in a decade, alcoholic liver disease (37%) of all liver disease deaths mental and behavioural disorders associated with alcohol use risen over the past 10 years ...

Pharmaceutical in Japan and The United Kingdom : Innovation and Technology Trends

  • Industry report
  • December 2013
  • 22 pages
  • by Corporation

... arthritis diabetes high satisfaction with treatment diseases with high contribution from medications diabetes complication alzheimer's disease presence of unmet medical needs low ...

Pharmaceutical Sector in The United Kingdom

  • Industry report
  • September 2013
  • 11 pages

... That are of long duration, and generally slow to progress; therefore, these diseases are also called chronic diseases. For the purpose of this discussion, we focus on four of the most common ncds: cardiovascular ...

Dementia Sector in The United Kingdom

  • Industry report
  • July 2013
  • 7 pages

... Requirements [4]. Old people with alzheimer s disease or other forms of dementia comprise the largest group affected by these changes. Early mental health surveys of older people served to demonstrate ...

The British Pharmaceutical Industry

  • Industry report
  • May 2013
  • 36 pages

... Nephropathy Associated with increased risk of Retinopathy cardiovascular disease Reversible in up to 50% if treated early if negative, emu for acr if acr positive, repeat 2x within 12 weeks ...

The British Pharmaceutical Industry

  • Industry report
  • May 2013
  • 31 pages
  • by Corporation

... critical illness, income protection and whole of life cover market has circa 765m ape1 written each year key players are legal & general, aviva, scottish widows, friends life and royal london group 2 ...

Pharmaceutical in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 23 pages

... Official figures show. Circulatory conditions like heart disease remain the most common cause of death, contributing to a third of the deaths registered. But over the decade, mortality from ...

Mental Health Sector (mental health, mental disorder) in The United Kingdom

  • Industry report
  • April 2013
  • 43 pages
  • by Corporation

The British Pharmaceutical Business

  • Industry report
  • April 2013
  • 39 pages

... The most consistent predictor of back pain after adjustment for age, sex, skill level, back pain severity and other potential confounders, the most consistent predictors of back pain were: ...

Pharmaceutical Sector in Europe

  • Industry report
  • March 2013
  • 23 pages

... Date name presentation title circlecopyrt conclusions recognition that the population is changing: elderly population is increasing; treatment of cancer in elderly will increase. Current ...

Search in Pathology Industry

» Purchase Premium Reports (From $ 250 - $ 6 995)

About 500 reports
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, ...

Epicast Report: Allergic Rhinitis - Epidemiology Foreca ...

April 2014 $ 3 995

Seroquel (schizophrenia) - Forecast And Market Analysis ...

February 2014 $ 3 495

Risperdal (schizophrenia) - Forecast And Market Analysi ...

February 2014 $ 3 495

Aripiprazole Lauroxil (schizophrenia) - Forecast And Ma ...

February 2014 $ 3 495

Cariprazine (schizophrenia) - Forecast And Market Analy ...

February 2014 $ 3 495

Brexpiprazole (schizophrenia) - Forecast And Market Ana ...

February 2014 $ 3 495

Zicronapine (schizophrenia) - Forecast And Market Analy ...

February 2014 $ 3 495

Bitopertin (schizophrenia) - Forecast And Market Analys ...

February 2014 $ 3 495

Evp-6124 (schizophrenia) - Forecast And Market Analysis ...

February 2014 $ 3 495

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.